Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05836103 · ClinicalTrials.gov registry record · NA
Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation
A NA study of Tobacco Cigarette Smoking, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT05836103: Recruiting NA study of Tobacco Cigarette Smoking, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT05836103 is a NA study of Tobacco Cigarette Smoking that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05836103, a NA study of Tobacco Cigarette Smoking, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Clinical practice guidelines for smoking cessation emphasize cognitive behavioral therapy (CBT) to help patients develop coping strategies for urges. Mindfulness or Acceptance and Commitment Therapy (ACT) offer a different approach, which teaches smokers psychological flexibility through accepting negative experiences. While there is evidence for the efficacy of both CBT and Mindfulness/ACT smoking cessation interventions, it is unclear if these approaches are efficacious when implemented in real-time and with young adults. The overall goal of this proposal is to evaluate the efficacy of CBT and Mindfulness/ACT messages for young adults targeted at specific high-risk situations for smoking.
Primary Outcome
The primary outcome will be change in participants' rating of smoking urge in EMA-post surveys, prompted 15 minutes after intervention message delivery, and controlling for the ratings in EMA-pre surveys. Urge will be assessed by a single item on a 5-point scale, ranging from 1 (very low) to 5 (very high).
Conditions Studied
Interventions
- BEHAVIORAL Smartphone-based intervention messages
Study Locations (1)
Maryland
- Johns Hopkins Bloomberg School of Public Health - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2024-10-22 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT05836103 shows while recruiting
NCT05836103 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Tobacco Cigarette Smoking appearing as the primary indexed condition, and to 1 intervention - of which Smartphone-based intervention messages is the first listed.
NCT05836103 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05836103 about?
NCT05836103 is a clinical study titled "Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation". Clinical practice guidelines for smoking cessation emphasize cognitive behavioral therapy (CBT) to help patients develop coping strategies for urges. Mindfulness or Acceptance and Commitment Therapy (ACT) offer a different approach, which teaches smokers psychological flexibility through accepting n...
What is the current status of trial NCT05836103?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2024-10-22. Estimated completion is 2026-06-30.
What conditions does trial NCT05836103 study?
This clinical trial studies the following conditions: Tobacco Cigarette Smoking.
What interventions are being tested in trial NCT05836103?
The interventions under investigation include: Smartphone-based intervention messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT05836103?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05836103 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05836103's enrollment target sits among peer trials
160 628th of 2000 higher than 1,348 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI